A Randomized Trial of 4% Nebulized Lignocaine vs. 10% Lignocaine Spray in Patients Undergoing Flexible Bronchoscopy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

1,050

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Patients With Indication for Flexible Bronchoscopy
Interventions
DRUG

Nebulized Lignocaine

2.5 ml of 4% lignocaine will be administered via nebulization prior to bronchoscopy

DRUG

Lignocaine spray

10 puffs of 10% (10mg/puff) lignocaine spray will be sprayed at 10 seconds intervals into the pharynx immediately prior to bronchoscopy

DRUG

Combined spray and nebulization

Combination of 2.5 ml of 4% lignocaine via nebulization prior to bronchoscopy and 2 puffs of 10% (10mg/puff) lignocaine spray sprayed at 10 seconds intervals into the pharynx immediately prior to bronchoscopy

Trial Locations (1)

160012

Bronchoscopy suite, PGIMER, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT03109392 - A Randomized Trial of 4% Nebulized Lignocaine vs. 10% Lignocaine Spray in Patients Undergoing Flexible Bronchoscopy | Biotech Hunter | Biotech Hunter